Cardiovascular

Latest News

Doctor taking child's blood pressure | Image credit: romaset – stock.adobe.com
3 Maternal Risk Factors Linked to Elevated Offspring Blood Pressure

May 14th 2025

Offspring born to mothers with prepregnancy obesity, gestational diabetes, or hypertensive disorders of pregnancy had higher systolic and diastolic blood pressure levels than those born to mothers without these risk factors.

Nurse using stethoscope on older patient | Image credit: InsideCreativeHouse – stock.adobe.com
Is Frailty Index the Most Accurate Predictor of CVD?

May 9th 2025

Antoine Keller, MD
Striving for Health Equity: Antoine Keller, MD

May 9th 2025

Effect of Remote Patient Monitoring on Stage 2 Hypertension
Effect of Remote Patient Monitoring on Stage 2 Hypertension

May 6th 2025

Q&A with Sid Patel, MD
Abelacimab Demonstrates Safety and Efficacy for Patients With AFib of All Ages: Sid Patel, MD

April 24th 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

AJMC Peer Exchange logo
Continuing Medical Education
View All
May 15th 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
May 15th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
May 15th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

Site Logo
July 28th 2016

Sanofi's Lixisenatide Approved, Paving Way for OK of Combo Therapy

Mary Caffrey
The approval paves the way for Sanofi's insulin and GLP-1 combination therapy, which is due for final FDA action in August.
Site Logo
July 25th 2016

CMS Proposes Mandatory Bundled Payments for Cardiac Care

Mary Caffrey
This would be the second group of procedures targeted for bundled payments in Medicare. Rules for hip and knee replacements went into effect in April in 67 markets.
Site Logo
July 20th 2016

Patients at High Risk for Cardiovascular Events Not Taking Optimum Statin Doses

Jackie Syrop
Despite evidence and clinical guidelines that support intensive statin use in high-risk patients, very few eligible patients start treatment at recommended levels.
Site Logo
July 18th 2016

Impact of a Physician-Led Point of Care Medication Delivery System on Medication Adherence

Ana Palacio, MD, MPH Jessica Chen, MD Leonardo Tamariz, MD, MPH Sylvia D. Garay, MD Hua Li, PhD Olveen Carrasquillo, MD, MPH
A point of care medication delivery system improves medication adherence to cardiovascular medications without increasing costs.
Site Logo
July 5th 2016

FDA Panel Narrowly OKs Empagliflozin CV Benefit Claim

Mary Caffrey
If the full FDA accepts the panel's narrow recommendation, the type 2 diabetes therapy could enjoy a preferred status above its rivals in the SGLT2 market.
Site Logo
June 23rd 2016

Diabetes Raises Fatal Heart Attack Risk by 50%

Mary Caffrey
The study comes as regulators put increased emphasis on long-term cardiovascular outcomes trials to ensure safety of diabetes and obesity therapies. The American Journal of Managed Care recently convened an expert panel on the topic.
Site Logo
June 15th 2016

Value of Improved Lipid Control in Patients at High Risk for Adverse Cardiac Events

Anupam B. Jena, MD, PhD Daniel M. Blumenthal, MD, MBA Warren Stevens, PhD Jacquelyn W. Chou, MPP, MPL Thanh G.N. Ton, PhD Dana P. Goldman, PhD
Reducing lipid levels in high-risk patients can significantly reduce disease burden and, depending on final negotiated prices, PCSK9 inhibitors can make an economic contribution to this goal.
Raising the Bar on Cardiovascular Benefit
May 27th 2016

Raising the Bar on Cardiovascular Benefit

Examining Cardiovascular Outcomes Trials
May 27th 2016

Examining Cardiovascular Outcomes Trials

GLP-1 Receptor Agonists and Cardiovascular Benefit
May 27th 2016

GLP-1 Receptor Agonists and Cardiovascular Benefit

Understanding the Safety Data in CANVAS
May 27th 2016

Understanding the Safety Data in CANVAS

Practical Implications of the CANVAS Trial
May 27th 2016

Practical Implications of the CANVAS Trial

Diabetes: Shifting Mindset for Cardiovascular Benefits
May 27th 2016

Diabetes: Shifting Mindset for Cardiovascular Benefits

Complexities in Diabetes Care in 2017
May 27th 2016

Complexities in Diabetes Care in 2017

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia
May 27th 2016

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

Role of the Health Plan in Providing Support to Members With Diabetes
May 27th 2016

Role of the Health Plan in Providing Support to Members With Diabetes

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia
May 27th 2016

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

An Increased Emphasis on Individual Risk Factors and Goals
May 27th 2016

An Increased Emphasis on Individual Risk Factors and Goals

Impact of Cost on Patients' Access to Treatment
May 27th 2016

Impact of Cost on Patients' Access to Treatment

How Drug Cost Influences Drug Selection
May 27th 2016

How Drug Cost Influences Drug Selection

Role of Early Intervention in Preventing Progression to T2D
May 27th 2016

Role of Early Intervention in Preventing Progression to T2D

Major Cost Drivers in T2D Management
May 27th 2016

Major Cost Drivers in T2D Management

Updates to Treatment Guidelines: Effects on Payers
May 27th 2016

Updates to Treatment Guidelines: Effects on Payers

Advantages of Medications that Treat Multiple Conditions
May 27th 2016

Advantages of Medications that Treat Multiple Conditions

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment
May 27th 2016

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Considerations Regarding Statin Therapy
May 27th 2016

Considerations Regarding Statin Therapy

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications
May 27th 2016

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Addressing the Effect of Polypharmacy on Medication Adherence
May 27th 2016

Addressing the Effect of Polypharmacy on Medication Adherence

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes
May 27th 2016

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

Partnering With Providers to Prevent or Delay Complications Related to Diabetes
May 27th 2016

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

<1
...
15161718192021222324>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo